Proqr Therapeutics (PRQR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -23,131 | -16,120 | N/A | N/A |
| Depreciation Amortization | 533 | 160 | N/A | N/A |
| Other Working Capital | 707 | 1,440 | N/A | N/A |
| Other Operating Activity | -5,017 | -4,690 | 0 | 0 |
| Operating Cash Flow | $-26,907 | $-19,210 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,439 | -1,470 | N/A | N/A |
| Purchase Sale Intangibles | -31 | N/A | N/A | N/A |
| Other Investing Activity | -31 | -160 | 0 | 0 |
| Investing Cash Flow | $-1,470 | $-1,630 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 1,821 | N/A | N/A | N/A |
| Common Stock Issued | 16 | N/A | N/A | N/A |
| Other Financing Activity | -38 | 159,360 | 0 | 0 |
| Financing Cash Flow | $1,799 | $159,360 | $N/A | $N/A |
| Exchange Rate Effect | 6,735 | 138,500 | N/A | N/A |
| Beginning Cash Position | 125,182 | 5,480 | N/A | N/A |
| End Cash Position | 105,338 | 149,860 | N/A | N/A |
| Net Cash Flow | $-19,844 | $144,370 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -26,907 | -19,210 | N/A | N/A |
| Capital Expenditure | -1,439 | N/A | N/A | N/A |
| Free Cash Flow | -28,346 | -19,210 | 0 | 0 |